From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer
Seminars in Cancer Biology · 2025-12 · 117 · 69-88
DOI: 10.1016/j.semcancer.2025.10.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025-12. Verfasst von Lídia Cedó und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Research Unit, Institut d'Investigació Sanitària Pere Virgili (IISPV), Hospital Universitari de Tarragona …. Hauptthemen laut MEDLINE: Atherosclerosis, Fatty Acids, Volatile, Gastrointestinal Microbiome, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 281 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Carlos III Health Institute, Biomedical Research Network Centre of Diabetes and Associated Metabolic Diseases, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Atherosclerosis and cancer are two of the most prevalent chronic diseases worldwide, representing leading causes of morbidity and mortality. These conditions share overlapping risk factors and pathophysiological mechanisms, including persistent inflammation, oxidative stress, immune dysregulation, aberrant apoptosis, uncontrolled proliferation, and angiogenesis. In recent years, the gut microbiota and its metabolites have emerged as key players in these processes. Beyond serving as markers of dysbiosis, microbial-derived compounds actively influence host physiology by modulating immune responses, inflammatory pathways, and metabolic homeostasis. This review explores the shared pathological links between atherosclerosis and cancer through the lens of microbial-derived metabolites, with a particular focus on short-chain fatty acids and their precursors, lactate and succinate. We discuss the mechanisms by which these metabolites influence disease progression -including G protein-coupled receptor activation and epigenetic modulation-, and therapeutic strategies aimed at modulating these metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Research Unit, Institut d'Investigació Sanitària Pere Virgili (IISPV), Hospital Universitari de Tarragona Joan XXIII, Tarragona 43005, Spain; CIBER de Diabetes y Enfermedades M…
Förderung
- Carlos III Health Institute
- Biomedical Research Network Centre of Diabetes and Associated Metabolic Diseases
- Ministerio de Ciencia e Innovación
- Spain Ministry of Science and Innovation
Zitieren
APA
Cedó, L., Madeira, A., & Caro, P. (2025). From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer. Seminars in Cancer Biology, 117, 69-88. https://doi.org/10.1016/j.semcancer.2025.10.007
Vancouver
Cedó L, Madeira A, Caro P. From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer. Seminars in Cancer Biology. 2025;117:69-88. doi:10.1016/j.semcancer.2025.10.007
BibTeX
@article{Ced2025,
author = {Cedó, Lídia and Madeira, Ana and Caro, Pau},
title = {From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer},
journal = {Seminars in Cancer Biology},
year = {2025},
volume = {117},
pages = {69--88},
doi = {10.1016/j.semcancer.2025.10.007}
}
EUVIMED